ON DEMAND CANAKINUMAB THERAPY FOR COLCHICINE RESISTANT FAMILIAL MEDITERRANEAN FEVER (FMF) PAEDIATRIC PATIENTS - A MULTICENTER STUDY

被引:0
|
作者
Shehadeh, K. [1 ]
Levinsky, Y. [1 ,2 ]
Tal, R. [1 ,2 ]
Kagan, S. [3 ]
Zoabi, T. [3 ]
Harel, L. [1 ,2 ]
Amarilyo, G. [1 ,2 ]
机构
[1] Tel Aviv Univ, Scakler Sch Med, Tel Aviv, Israel
[2] Schneider Childrens Med Ctr, Pediat Dept B, Petah Tiqwa, Israel
[3] Schneider Childrens Med Ctr, Pediat Dept B, Petah Tiqwa, Israel
关键词
Quality of care;
D O I
10.1136/annrheumdis-2023-eular.6147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS0758
引用
收藏
页码:670 / 671
页数:2
相关论文
共 50 条
  • [1] The feasibility of withdrawing canakinumab in paediatric colchicine-resistant familial Mediterranean fever patients
    Sozeri, B.
    Sonmez, H. E.
    Karadag, S. G.
    Baglan, E.
    Ozturk, K.
    Cakan, M.
    Demir, F.
    Yener, G. Otar
    Ozdel, S.
    Ayaz, N. Aktay
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : S118 - S123
  • [2] Can Children with Colchicine Resistant FMF Be Treated with on Demand Canakinumab Regimen?- a Multicenter Study
    Shehadeh, Katy
    Levinsky, Yoel
    Tal, Rotem
    Aviran, Neta Hana
    Aviel, Yonatan Butbul
    Tirosh, Irit
    Kagan, Shelly
    Zoabi, Tarek
    Spielman, Shiri
    Miller-Barmak, Adi
    Oz, Rotem Semo
    Harel, Liora
    Chodick, Gabriel
    Amarilyo, Gil
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 105 - 105
  • [3] Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
    El Hasbani, Georges
    Jawad, Ali
    Uthman, Imad
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (01)
  • [4] An "On Demand" canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study
    Shehadeh, Katy
    Levinsky, Yoel
    Kagan, Shelly
    Zuabi, Tarek
    Tal, Rotem
    Aviran, Neta Hana
    Aviel, Yonatan Butbul
    Tirosh, Irit
    Spielman, Shiri
    Miller-Barmak, Adi
    Oz, Rotem Semo
    Harel, Liora
    Chodick, Gabriel
    Amarilyo, Gil
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 132
  • [5] Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)
    Georges El Hasbani
    Ali Jawad
    Imad Uthman
    [J]. Orphanet Journal of Rare Diseases, 14
  • [6] Alternative treatments in colchicine-resistant patients with familial mediterranean fever (FMF).
    Seyahi, Emire
    Ozdogan, Huri
    Yazici, Hasan
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S143 - S143
  • [7] Thalidomide and etanercept in colchicine-resistant patients with familial Mediterranean fever (FMF)
    Ozdogan, H.
    Seyahi, E.
    Yazici, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 270 - 270
  • [8] Canakinumab treatment in four children with colchicine resistant familial mediterranean fever
    Ozkan, Solmaz
    Atas, Bulent
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (06) : 945 - 947
  • [9] Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases
    Yucel, Burcu Bozkaya
    Aydog, Ozlem
    Nalcacioglu, Hulya
    Yilmaz, Aysegul
    [J]. FRONTIERS IN PEDIATRICS, 2021, 9
  • [10] Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment
    Yusuf Karabulut
    Halise Hande Gezer
    Mehmet Tuncay Duruöz
    [J]. Rheumatology International, 2022, 42 : 81 - 86